Discovery of Molecular Probes and Therapeutic Leads, Administrative Supplement for Equipment
分子探针和治疗先导物的发现,设备管理补充
基本信息
- 批准号:10400299
- 负责人:
- 金额:$ 25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdjuvantAdministrative SupplementAnalytical ChemistryAwardBiochemistryBiologicalBiologyCapsidCellsCenters of Research ExcellenceChemicalsCollaborationsCommunicable DiseasesComplementCore FacilityCustomDelawareDiseaseEngineeringEnzymesEquipmentExtramural ActivitiesFacultyFaculty RecruitmentFundingGoalsGrantHIVHumanHuman BiologyImmune responseInfrastructureKineticsLaboratoriesLegionnaires&apos DiseaseLungMacromolecular ComplexesMalignant NeoplasmsMass Spectrum AnalysisMentorsMessenger RNAMicroscopyMolecularMolecular ProbesMolecular TargetPathway interactionsPhasePilot ProjectsRegulationResearchResearch PersonnelResource SharingServicesStructureTherapeuticTuberculosisUniversitiesVirusbasecatalystcohortdemethylationdesignhuman diseaseinstrumentationinterestmembermultidisciplinarynanoparticlenucleotide analogpathogenic bacteriaprofessorprogramsrecruitscreeningsmall moleculesuccesstoolvaccine development
项目摘要
Project Summary
The goal of this Center of Biomedical Research Excellence is to continue our efforts to develop molecular
approaches for probing biology, to discover and apply new chemical biology tools for the study of biological
pathways associated with disease, and to develop computational approaches for understanding small
molecule interactions with complex macromolecular targets. With core strengths in synthesis, biochemistry,
engineering and biology, our scientific team will develop new chemical biology tools for understanding the
cellular and molecular mechanisms that bacterial pathogens use to survive and replicate inside host cells, new
chemical tools and nucleotide analogs to understand the regulation of mRNA demethylation by a ‘methyl
eraser’ enzyme and its dysregulation in human cancer, molecularly-defined nanoparticle adjuvants that yield
specific immune responses in the lung to advance inhalable vaccine development, and computational
approaches to elucidate the mechanisms by which small molecules regulate the structure and function of virus
capsids.
COBRE funding will be used to recruit two new faculty members who will complement the existing strengths of
our center, which will be expanded through competitive pilot grants. In years 4 and 5 of the COBRE, five two-
year replacement projects will be funded. Collaboration and resource sharing in the Delaware and national
IDeA network will be critical for maximizing our research capacity, core facilities and mentoring network. In
Phase II, this COBRE continue to develop unique core facilities that facilitates high throughput synthesis,
purification, screening and analysis of chemical probes. Building on the infrastructure established in Phase I,
we will support a core facility in Analytical Chemistry, which will provide support for critical core facilities in
mass spectrometry, solution NMR and kinetic analysis. The center will also support a Synthesis and Discovery
core facility, which will provide custom synthesis services and instrumentation and infrastructure for small
molecule synthesis, high throughput catalyst discovery, parallel synthesis, computation and microscopy.
项目概要
该生物医学卓越研究中心的目标是继续努力开发分子生物学
探索生物学的方法,发现和应用新的化学生物学工具来研究生物
与疾病相关的途径,并开发计算方法来理解小
分子与复杂大分子靶标的相互作用。拥有合成、生物化学等核心优势,
工程和生物学,我们的科学团队将开发新的化学生物学工具来理解
细菌病原体在宿主细胞内生存和复制的细胞和分子机制,新
化学工具和核苷酸类似物来了解“甲基”对 mRNA 去甲基化的调节
擦除酶及其在人类癌症中的失调,分子定义的纳米颗粒佐剂,产生
肺部的特异性免疫反应,以推进可吸入疫苗的开发和计算
阐明小分子调节病毒结构和功能机制的方法
衣壳。
COBRE 资金将用于招募两名新教员,以补充现有的优势
我们的中心将通过竞争性试点拨款进行扩大。在 COBRE 的第 4 年和第 5 年,有五个二-
年更换项目将获得资助。特拉华州和国家的合作和资源共享
IDeA 网络对于最大化我们的研究能力、核心设施和指导网络至关重要。在
第二阶段,COBRE 继续开发独特的核心设施,促进高通量合成,
化学探针的纯化、筛选和分析。在第一阶段建立的基础设施的基础上,
我们将支持分析化学领域的核心设施,该设施将为分析化学领域的关键核心设施提供支持
质谱、溶液核磁共振和动力学分析。该中心还将支持综合和发现
核心设施,将为小型企业提供定制合成服务以及仪器和基础设施
分子合成、高通量催化剂发现、并行合成、计算和显微镜。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH M FOX其他文献
JOSEPH M FOX的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH M FOX', 18)}}的其他基金
Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包
- 批准号:
9899272 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包
- 批准号:
10660115 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
NIH ADMINISTRATIVE SUPPLEMENT FPLC SYSTEM FOX
NIH 行政补充 FPLC 系统 FOX
- 批准号:
9925864 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
Supplement to Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包的补充
- 批准号:
10046448 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包
- 批准号:
10343710 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
Discovery of Chemical Probes and Therapeutic Leads, Phase II
化学探针和治疗先导化合物的发现,第二阶段
- 批准号:
10654734 - 财政年份:2014
- 资助金额:
$ 25万 - 项目类别:
Discovery of Chemical Probes and Therapeutic Leads: Cryoprobe Upgrade of a 400 MHz NMR
化学探针和治疗先导化合物的发现:400 MHz NMR 的冷冻探针升级
- 批准号:
10581950 - 财政年份:2014
- 资助金额:
$ 25万 - 项目类别:
Discovery of Chemical Probes and Therapeutic Leads, Phase 2
化学探针和治疗先导化合物的发现,第二阶段
- 批准号:
10853967 - 财政年份:2014
- 资助金额:
$ 25万 - 项目类别:
相似海外基金
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:














{{item.name}}会员




